Financhill
Back

Immuneering Stock Predictions

Immuneering Stock Forecast

  • Is Immuneering Stock Undervalued?
    The current Immuneering [IMRX] share price is $2.20. The Score for IMRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • IMRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Immuneering Stock Go Up Next Year?

Data Unavailable

Immuneering Stock Rating

Data Unavailable

Immuneering Stock Price History

Is IMRX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immuneering.com

52-Week Data

52-Week High:
7.92
52-Week Low:
1.00

Prediction Charts

Market Cap:
68.3M
Price in USD:
2.20
Volume:
597.8K
Beta:
-0.34

Technical Analysis

SMA50:
2.01
SMA100:
1.87
SMA200:
1.82
52-Wk Change:
-68.57%

Stock Predictions

  • Is Immuneering stock public?
    Yes, Immuneering is a publicly traded company.
  • What is the Immuneering stock quote today?
    The Immuneering stock price is 2.20 USD today.
  • How to buy Immuneering stock online?
    You can buy Immuneering shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-4 2.08 2.29 2.33 2.06
Dec-5 2.34 2.14 2.34 2.10
Dec-6 2.14 2.18 2.22 2.11
Dec-9 2.23 2.14 2.23 2.07
Dec-10 2.13 2.17 2.20 2.06
Dec-11 2.14 2.14 2.18 2.10
Dec-12 2.07 1.97 2.30 1.96
Dec-13 1.85 1.64 1.88 1.52
Dec-16 1.63 1.73 1.80 1.60
Dec-17 1.88 1.73 1.93 1.71
Dec-18 1.71 1.63 1.81 1.61
Dec-19 1.60 1.84 1.86 1.56
Dec-20 1.79 2.01 2.08 1.79
Dec-23 2.04 2.20 2.24 1.96

Immuneering Earnings

Data Unavailable

Immuneering Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.17 per share.

* Immuneering stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.